Stancorp Investment Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$157K Sell
979
-202
-17% -$31.8K 0.07% 177
2014
Q4
$188K Buy
+1,181
New +$184K 0.09% 172

Other funds holding AMGN

Stancorp Investment Advisers's AMGN Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its Amgen (AMGN) stake by 17% in Q1 2015, selling an estimated $31.8K and leaving 979 shares worth $157K. The position accounts for 0.07% of the portfolio, ranked #177.

Stancorp Investment Advisers first reported a position in AMGN in Q4 2014 and has held it in 2 quarters since. The position peaked at $188K in Q4 2014. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Stancorp Investment Advisers held 979 shares of Amgen worth $157K as of Q1 2015.
  • Stancorp Investment Advisers sold 202 Amgen shares in Q1 2015, an estimated $31.8K.
  • Amgen made up 0.07% of Stancorp Investment Advisers's portfolio in Q1 2015, its #177 holding.
  • Stancorp Investment Advisers first reported a position in Amgen in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's Amgen position peaked at $188K in Q4 2014.
  • 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.